[go: up one dir, main page]

MX2009006074A - Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas. - Google Patents

Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas.

Info

Publication number
MX2009006074A
MX2009006074A MX2009006074A MX2009006074A MX2009006074A MX 2009006074 A MX2009006074 A MX 2009006074A MX 2009006074 A MX2009006074 A MX 2009006074A MX 2009006074 A MX2009006074 A MX 2009006074A MX 2009006074 A MX2009006074 A MX 2009006074A
Authority
MX
Mexico
Prior art keywords
epothilones
osteoporosis
treatment
related diseases
dysbalance
Prior art date
Application number
MX2009006074A
Other languages
English (en)
Inventor
Jens Hoffmann
Ulrich Klar
Sanna Kaekoenen
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38008136&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009006074(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of MX2009006074A publication Critical patent/MX2009006074A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se relaciona con el uso de epotilonas naturales o sintéticas para el tratamiento, la prevención o la mitigación de enfermedades causadas por el desequilibrio de la actividad y osteoblástica, especialmente las osteoporosis.
MX2009006074A 2006-12-08 2007-12-05 Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas. MX2009006074A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06025424A EP1930004A1 (en) 2006-12-08 2006-12-08 Use of epothilones in the treatment of osteoporosis and related diseases
PCT/EP2007/010789 WO2008068043A1 (en) 2006-12-08 2007-12-05 Use of epothilones in the treatment of osteoporosis and related diseases

Publications (1)

Publication Number Publication Date
MX2009006074A true MX2009006074A (es) 2009-08-24

Family

ID=38008136

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006074A MX2009006074A (es) 2006-12-08 2007-12-05 Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas.

Country Status (15)

Country Link
US (1) US20080146626A1 (es)
EP (2) EP1930004A1 (es)
KR (1) KR20090087038A (es)
CN (1) CN101553227A (es)
AR (1) AR064214A1 (es)
AU (1) AU2007327767A1 (es)
BR (1) BRPI0719997A2 (es)
CA (1) CA2672114A1 (es)
CL (1) CL2007003553A1 (es)
IL (1) IL198493A0 (es)
MX (1) MX2009006074A (es)
TW (1) TW200829239A (es)
UY (1) UY30769A1 (es)
WO (1) WO2008068043A1 (es)
ZA (1) ZA200904755B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110300150A1 (en) 2010-05-18 2011-12-08 Scott Eliasof Compositions and methods for treatment of autoimmune and other disease
RU2496511C1 (ru) * 2012-04-20 2013-10-27 Замертон Холдингс Лимитед Фармацевтическая композиция, средство (варианты) и способ профилактики и лечения артрита, остеоартроза и остеохондроза позвоночника (варианты)
CN108430996A (zh) * 2015-10-16 2018-08-21 威廉马歇莱思大学 埃博霉素类似物、合成方法、治疗方法及其药物缀合物
CN110974824A (zh) * 2019-12-18 2020-04-10 中国人民解放军陆军军医大学第一附属医院 埃博霉素b在制备防治炎症性骨丢失药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6320045B1 (en) * 1997-12-04 2001-11-20 Bristol-Myers Squibb Company Process for the reduction of oxiranyl epothilones to olefinic epothilones
US6893859B2 (en) * 2001-02-13 2005-05-17 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
AU2002338336A1 (en) * 2001-04-03 2002-10-21 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
US20060069136A1 (en) * 2004-09-24 2006-03-30 Ulrich Klar Use of Epothilones in the treatment of bone metastasis
EP1640004A1 (en) * 2004-09-24 2006-03-29 Schering Aktiengesellschaft Use of epothilones in the treatment of bone metastases and bone tumors or cancers

Also Published As

Publication number Publication date
ZA200904755B (en) 2010-09-29
EP2101765A1 (en) 2009-09-23
AR064214A1 (es) 2009-03-18
CL2007003553A1 (es) 2008-07-04
IL198493A0 (en) 2010-02-17
BRPI0719997A2 (pt) 2014-03-18
CN101553227A (zh) 2009-10-07
UY30769A1 (es) 2008-07-31
EP1930004A1 (en) 2008-06-11
CA2672114A1 (en) 2008-06-12
KR20090087038A (ko) 2009-08-14
AU2007327767A1 (en) 2008-06-12
WO2008068043A1 (en) 2008-06-12
US20080146626A1 (en) 2008-06-19
TW200829239A (en) 2008-07-16

Similar Documents

Publication Publication Date Title
IN2012DN00624A (es)
AU2007257423A8 (en) Purine analogs
MX2013007379A (es) Mutantes tipo papel lija de bacillus y metodos de uso de los mismos para mejorar el crecimiento vegetal, promover la salud de plantas y controlar enfermedades y plagas.
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
MX2009013353A (es) Compuestos activadores de telomerasa y metodos para su uso.
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
MY163275A (en) Ibat inhibitors for the treatment of liver diseases
MX2020012825A (es) Compuestos multiciclicos y metodos de uso de los mismos.
WO2011005942A3 (en) Oligonucleotide-based compounds as inhibitors of toll-like receptors
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
TN2009000214A1 (en) Manufacture process
IL195341A0 (en) Methods and materials for making simvastatin and related compounds
WO2008156685A3 (en) Tendon stem cells
SI2176253T1 (sl) Postopek priprave ali čiščenja olmesartan medoksomila ali hidrohalidne soli olmesartan medoksomila
MX2009003981A (es) Agentes moduladores del receptor de calcio.
MX2011013032A (es) Inhibidores de fosfatidilinositol 3-cinasa.
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
BRPI0720050A2 (pt) 6-oxo-1,6-diidropirimidin-2-ilas no tratamento de doenças proliferativas
MX2007012538A (es) Uso de lactobacillus gg en la manufactura de un medicamento para la prevencion o tratamiento de alergias respiratorias.
TNSN08496A1 (en) Aminothiazoles and their uses
MX2009001315A (es) Compuestos de dimetilciclobutilo substituidos, su preparación y uso en medicamentos.
IN2012DN03096A (es)
EP2207555A4 (en) NOVEL COMPOUNDS FOR THE TREATMENT OR MITIGATION OF OEDEMES, AND METHODS OF USE THEREOF
MX2009006074A (es) Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas.
MY161839A (en) A composition for use in the prevention and treatment of cardiovascular diseases

Legal Events

Date Code Title Description
FA Abandonment or withdrawal